webinar register page

Webinar banner
Marijuana’s High Impact: The Evolving Landscape of Drug Testing
Did you know that about 38 states have approved of some sort of marijuana use whether medicinally or recreationally? Cannabis laws are rapidly changing, so how are you keeping up and does your drug screening policy fit in?

At Asurint, we’re committed to helping you better understand considerations and legal ramifications in the marijuana space. So let’s help you weed through the facts. Join us December 12th at 12 p.m. EST for our latest webinar, “Marijuana’s High Impact: The Evolving Landscape of Drug Testing.”

Asurint’s General Counsel, Kelly Uebel will provide a high-level overview of the legal landscape surrounding medical and recreational marijuana. You’ll also get a free recording of the webinar, and a whitepaper to share with your team.

- State law considerations regarding marijuana use
- Legal ramifications for employers
- Decriminalization of marijuana cases
- Drug testing opportunities and barriers

Be a bud and sign up today!

Dec 12, 2019 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information


Kelly Uebel
General Counsel @Asurint
Kelly Uebel is Asurint’s General Counsel with 9 years of experience in the screening industry. In her current role, Kelly oversees the teams responsible for counseling staff on legal and regulatory risks and requirements. This includes providing subject matter expertise, and monitoring and evaluating proposed and existing laws and regulations from the local, state, federal and international level that impact background screening. Kelly also serves as Secretary/Treasurer for the Professional Background Screening Association (PBSA) and holds a law degree from William Mitchell College of Law. She is admitted to the Minnesota bar.